Overit Turkey
Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

ActiveGENILA.Ş.

Ankara · Registered 1997

Overview

Registered seat

Mustafa Kemal Mahallesi 2119 Sokak No: D:3 Çankaya Ankara

Website

genilac.com.tr

Registered

August 5, 1997

Paid-in capital

₺300m

Financial statements

Consolidated and standalone statements are shown separately and are never compared with one another.

Revenue₺2.50bn+16.3% Change
2019202020212022202320242025
Net profit / loss₺806m+328.8% Change
2019202020212022202320242025
Total assets₺19.5bn+19.7% Change
2019202020212022202320242025
Equity₺10.3bn+8% Change
2019202020212022202320242025
Year2025December 31, 20252024*December 31, 20242023December 31, 20232022*December 31, 20222021December 31, 20212020*December 31, 2020
Revenue————₺2.50bn₺2.15bn
Gross profit————₺456m₺333m
Operating profit————₺202m₺219m
EBITDA————₺246m₺239m
Profit before tax————₺301m₺217m
Net profit / loss₺806m₺188m₺452m₺641m₺310m₺207m
Cash and cash equivalents₺94.0m₺711m₺67.4m₺645m₺519m₺58.7m
Current assets₺9.87bn₺7.59bn₺3.95bn₺3.19bn₺1.46bn₺662m
Non-current assets₺9.58bn₺8.66bn₺3.76bn₺3.13bn₺656m₺416m
Total assets₺19.5bn₺16.2bn₺7.71bn₺6.32bn₺2.12bn₺1.08bn
Equity₺10.3bn₺9.57bn₺4.86bn₺4.95bn₺1.28bn₺557m
Current liabilities₺7.77bn₺5.49bn₺2.71bn₺1.12bn₺795m₺448m
Non-current liabilities₺1.35bn₺1.19bn₺141m₺253m₺40.2m₺72.5m
Total liabilities₺9.12bn₺6.68bn₺2.85bn₺1.38bn₺835m₺521m
Cash flow from operating activities₺1.49bn₺2.61bn₺4.51m₺379m₺159m₺98.7m

* Read from a later filing's comparative column. Reporting standard: TFRS. Presentation unit: TL.

Management

  • ABİDİN GÜLMÜŞYönetim Kurulu Başkanı
  • ALİ GÖLYönetim Kurulu Üyesi
  • BERNAY ÖZAVCIYönetim Kurulu ÜyesiIndependent
  • TOLGA KIZILTANYönetim Kurulu ÜyesiIndependent
  • EDA GÜLMÜŞ DEMİRGENEL MÜDÜR YAR. (DIŞ TİCARET)
  • MUSTAFA GÜRCAN ÜSGÜLENGENEL MÜDÜR YAR. (TEKNİK OPERASYONLAR)
  • NADİR ULUGENEL MÜDÜR YAR. (MEDİKAL, AR-GE VE KLİNİK OPERASYONLAR)
  • SELÇUK DENİZ KARAGÜLLEGENEL MÜDÜR YAR. (GLOBAL SATIŞ - PAZARLAMA)
  • YAĞMUR SELİN GÜLMÜŞ KOLAYGENEL MÜDÜR YAR. (İK, STRATEJİ VE KURUMSAL GELİŞİM)
  • ÖMER DİNÇERGENEL MÜDÜR YAR. (İDARİ İŞLER)
  • ŞÜKRÜ TÜRKMENYönetim Kurulu Başkan Vekili

Share classes

GroupRegistered / bearerShare (%)Nominal valuePrivilegeTraded
ARegistered—₺825mNot stated—
BRegistered—₺3.68bnNot stated—

A privileged group can carry rights — such as nominating board members — regardless of how small its share of capital is. A percentage of capital alone therefore does not show control.

Subsidiaries and participations

CompanyScopeShare (%)Nominal holding
Gen Ilac Germany GMBHSubsidiary100%€25,000
Genject Sağlık Ürünleri Kimya San.Ve Tic.A.Ş.Subsidiary96.4%₺20.5m
Elixir İlaç Araştırma ve Geliştirme A.Ş.Subsidiary95%₺950,000
Gen Pharma Caucasus Manufacturıng Operatıons MmcSubsidiary66%AZN30.1m
Neo Auvra Dijital Sağlık ve Biyonik Teknolojileri ve Hizmetleri Sanayi ve Ticaret A.Ş.Associate35.15%₺91,606
Stımusıl Inc.Associate19.3%$276,928
Rs Araştırma Eğitim Danışmanlık İlaç Sanayi ve Ticaret A.Ş.Associate13.65%₺35,407
H2o Bilişim Yazılım Elektronik Sağlık Hizmetleri Sanayi ve Ticaret Anonim ŞirketiAssociate10%₺638,889
Galventa AgAssociate4.41%CHF6,471
Invıos Holdıng AgFinancial investment0.98%₺52,221
Jaguar Health Inc.Associate0.08%$3,882

Disclosures

Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. | Overit